UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer’s Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

The Journal of Prevention of Alzheimer's Disease, 2023-01, Vol.10 (1), p.41-49

2023

Volltextzugriff (PDF)

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment

Neurobiology of aging, 2010-08, Vol.31 (8), p.1443-1451.e1

2010

Volltextzugriff (PDF)

Arguments Against Precompetitive Collaboration

Clinical pharmacology and therapeutics, 2010-05, Vol.87 (5), p.527-529

2010

Volltextzugriff (PDF)

PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders

Growth hormone & IGF research, 2011-10, Vol.21 (5), p.292-303

2011

Volltextzugriff (PDF)

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme

Journal of magnetic resonance imaging, 2002-03, Vol.15 (3), p.233-240

2002

Volltextzugriff (PDF)

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease

Brain (London, England : 1878), 2013-07, Vol.136 (Pt 7), p.2228-2238

2013

Volltextzugriff (PDF)

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

Journal of cerebral blood flow and metabolism, 2013-01, Vol.33 (1), p.53-58

2013

Volltextzugriff (PDF)

P06 Concordance of florbetapir (18F) PET and Elecsys® [formula omitted]-Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD

Clinical neurophysiology, 2019-08, Vol.130 (8), p.e148-e149

2019

Volltextzugriff (PDF)

P06 Concordance of florbetapir (18F) PET and Elecsys® β -Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD

Clinical neurophysiology, 2019-08, Vol.130 (8), p.e148-e149

2019

Volltextzugriff (PDF)

P32 Phase III studies of crenezumab in early (prodromal-to-mild) Alzheimers disease (CREAD/CREAD2): Biomarker results

Clinical neurophysiology, 2020-04, Vol.131 (4), p.e194-e195

2020

Volltextzugriff (PDF)

Biomarkers for Alzheimer's disease therapeutic trials

Progress in neurobiology, 2011-12, Vol.95 (4), p.579

2011

Volltextzugriff (PDF)

Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.438-444

2013

Volltextzugriff (PDF)

Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease

Parkinsonism & related disorders, 2018-01, Vol.46, p.e25-e25

2018

Volltextzugriff (PDF)

MEETING REPORTER

Current opinion in neurology, 2017-12, Vol.31 (1), p.1-24

2017

Volltextzugriff (PDF)

Assessing tumor angiogenesis using macromolecular MR imaging contrast media

Journal of magnetic resonance imaging, 1997-01, Vol.7 (1), p.68-74

1997

Volltextzugriff (PDF)

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment: Alzheimer's Disease Neuroimaging Initiative (ADNI) Studies

Neurobiology of aging, 2010, Vol.31 (8), p.1443-1451

2010

Volltextzugriff (PDF)

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

The Journal of nutrition, health & aging, 2012-04, Vol.16 (4), p.339-345

2012

Volltextzugriff (PDF)

Concurrence of cortex and platelet serotonin2 receptor binding characteristics in the individual and the putative regulation by serotonin

Journal of Neural Transmission, 1993-02, Vol.93 (1), p.27-35

1993

Volltextzugriff (PDF)

Single- and Multiple-Dose Pharmacokinetics of Levovirin Valinate Hydrochloride (R1518) in Healthy Volunteers

Journal of clinical pharmacology, 2005-05, Vol.45 (5), p.578-596

2005

Volltextzugriff (PDF)

Multispectral analysis of bone lesions in the hands of patients with rheumatoid arthritis

Magnetic resonance imaging, 2004-05, Vol.22 (4), p.505-514

2004

Volltextzugriff (PDF)

Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model

Journal of magnetic resonance imaging, 1998-07, Vol.8 (4), p.799-806

1998

Volltextzugriff (PDF)

Human brain cortex and platelet serotonin2 receptor binding properties and their regulation by endogenous serotonin

Life sciences (1973), 1993, Vol.52 (3), p.313-321

1993

Volltextzugriff (PDF)

Human brain cortex and platelet serotonin 2 receptor binding properties and their regulation by endogenous serotonin

Life sciences (1973), 1993, Vol.52 (3), p.313-321

1993

Volltextzugriff (PDF)

Human brain cortex and platelet serotonin sub(2) receptor binding properties and their regulation by endogenous serotonin

Life sciences (1973), 1993-01, Vol.52 (3), p.313-321

1993

Volltextzugriff (PDF)

Two cases of neurologigal manifestations in eosinophilia variations of one disease ?

The Clinical Investigator, 1994-12, Vol.72 (12), p.1060-1064

1994

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer’s Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment

Arguments Against Precompetitive Collaboration

PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

P06 Concordance of florbetapir (18F) PET and Elecsys® [formula omitted]-Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD

P06 Concordance of florbetapir (18F) PET and Elecsys® β -Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD

P32 Phase III studies of crenezumab in early (prodromal-to-mild) Alzheimers disease (CREAD/CREAD2): Biomarker results

Biomarkers for Alzheimer's disease therapeutic trials

Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force

Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease

MEETING REPORTER

Assessing tumor angiogenesis using macromolecular MR imaging contrast media

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment: Alzheimer's Disease Neuroimaging Initiative (ADNI) Studies

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

Concurrence of cortex and platelet serotonin2 receptor binding characteristics in the individual and the putative regulation by serotonin

Single- and Multiple-Dose Pharmacokinetics of Levovirin Valinate Hydrochloride (R1518) in Healthy Volunteers

Multispectral analysis of bone lesions in the hands of patients with rheumatoid arthritis

Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model

Human brain cortex and platelet serotonin2 receptor binding properties and their regulation by endogenous serotonin

Human brain cortex and platelet serotonin 2 receptor binding properties and their regulation by endogenous serotonin

Human brain cortex and platelet serotonin sub(2) receptor binding properties and their regulation by endogenous serotonin

Two cases of neurologigal manifestations in eosinophilia variations of one disease ?

Suchergebnisse filtern